 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Q-linea, Setting Sights on Clinical Dx Market, Aims to Launch Antibiotic Susceptibility Test by 2015
September 11, 2012
Q-linea, Setting Sights on Clinical Dx Market, Aims to Launch Antibiotic Susceptibility Test by 2015
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Nanosphere Releases Data on Gram-Positive Blood Culture Test Ahead of Anticipated FDA Approval
October 4, 2011 / BioArray News - At Investor Confab, Illumina Details 'Enormous' DTC Demand as Market Shifts to Less Complex Chips
May 21, 2013 / BioArray News - Q&A: INMEGEN's Alfredo Hidalgo on Using Genomics to Address Mexico's Most Pressing Health Problems
May 21, 2013 / BioArray News - SQI's Q2 Revenues Drop to Zero
May 21, 2013 / GenomeWeb Daily News - Aiming at '$12B Opportunity,' Illumina to Expand Sales Presence, Invest in Reproductive Health
May 14, 2013 / BioArray News